Celsion Corp (NASDAQ:CLSN)
| 1.27 Data as of 10:05am ET |  -0.04 / -3.05%Today’s Change | 0.75 Today|||52-Week Range 9.44 | -84.49% Year-to-Date |
Latest CLSN News | Press Releases
| Afternoon Market Losers Jun 17 / Benzinga | Biotech Stock Mailbag: Exact Sciences, Questcor, Biotech M&A, Celsion Jun 14 / TheStreet.com |
| Afternoon Market Losers Jun 14 / Benzinga | Celgene Soars in 2013; What Does the Future Hold? Jun 06 / MotleyFool.com |
Today’s Trading
| Previous close | 1.31 |
| Today’s open | 1.32 |
| Day’s range | 1.24 - 1.32 |
| Volume | 349,580 |
| Average volume (3 months) | 4,800,003 |
| Market cap | $74.8M |
| Dividend yield | -- |
Data as of 10:05am ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +31.53% |
| Earnings growth (this year) | +48.68% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.09 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PIPPharmAthene Inc | 0.00 | 0.00% |
| CYTRCytRx Corp | +0.03 | +1.50% |
| AGENAgenus Inc | -0.03 | -0.79% |
| LPTNLpath Inc | +0.01 | +0.22% |
Data as of 10:16am ET, 06/19/2013
Financials
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$26.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Michael H. Tardugno |
Chief Financial Officer & Senior Vice President Gregory L. Weaver, MBA, CPA |
Corporate headquarters Lawrenceville, New Jersey |
Forecasts
